Records containing: Ocular Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-03-16A Randomized, Double-Masked, Parallel-Group Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2009-01-14ClinicalTrials.gov study NCT00822081
-
CLINICAL_TRIALS study record update · 2009-01-14ClinicalTrials.gov study NCT00822055
-
CLINICAL_TRIALS study record update · 2009-01-12Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops
-
CLINICAL_TRIALS study record update · 2009-01-07A Randomized, Parallel-Group, Multi-Center, Investigator-Masked, Active-and Placebo-Controlled, Phase 1-2 Evaluation of the Safety and Efficacy of OT-730 Ophthalmic Solution in Reducing the Intraocular Pressure in Subjects With Ocular Hypertension or Open-Angle Glaucoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-12-08The International Collaborative Exfoliation Syndrome Treatment Study
-
CLINICAL_TRIALS study record update · 2008-12-05Dry Eye and Irritation Comparison of Latanoprost 0.005% With the Preservative Benzalkonium Chloride (BAC) Vs Travoprost 0.004% Without BAC
-
CLINICAL_TRIALS study record update · 2008-12-04Randomized, Investigator Masked Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
-
CLINICAL_TRIALS study record update · 2008-11-19ClinicalTrials.gov study NCT00273481
-
CLINICAL_TRIALS study record update · 2008-11-19ClinicalTrials.gov study NCT00273442
-
CLINICAL_TRIALS study record update · 2008-11-05A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2008-10-28A Randomized Clinical Trial Comparing the Intraocular Pressure Changes With the Use of Loteprednol and Dexamethasone After Pterygium Surgery
-
CLINICAL_TRIALS study record update · 2008-09-26ClinicalTrials.gov study NCT00440011
-
CLINICAL_TRIALS study record update · 2008-08-05Phase 3 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Japanese Subjects C-01-98.
-
CLINICAL_TRIALS study record update · 2008-08-05Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients (C-02-41).
-
CLINICAL_TRIALS study record update · 2008-08-05Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
-
CLINICAL_TRIALS study record update · 2008-08-05A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma.
-
CLINICAL_TRIALS study record update · 2008-08-05A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2008-08-05A Double-Masked, Placebo-Controlled, Paired Comparison Study of the Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2008-08-05A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2008-08-05Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-69.
-
CLINICAL_TRIALS study record update · 2008-08-05Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-70.
-
CLINICAL_TRIALS study record update · 2008-08-05A 6-Week Safety and Efficacy Study of TRAVATAN Compared to XALCOM in Subjects With Open-Angle Glaucoma or Ocular Hypertension.
-
CLINICAL_TRIALS study record update · 2008-07-29Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2008-05-08Comparison of Brimonidine 0.15% Purite, Dorzolamide 2%, and Brinzolamide 1% as Adjunctive Therapy to Prostaglandin Analogs